Hypofractionated radiotherapy may offer similar local control and toxicity outcomes in the management of soft tissue sarcomas (STS) compared to standard fractionation. Shorter-course radiotherapy regimens can reduce overall treatment time and delays in surgical intervention or systemic treatment. It may also improve patient compliance and reduce healthcare costs. In this comprehensive review, the current evidence on the use of hypofractionated radiotherapy in the treatment of STS is synthesized, and an overview is provided for how hypofractionated radiotherapy may be used in the treatment of STS.
与传统分割放疗相比,大分割放疗在软组织肉瘤治疗中可能提供相似的局部控制效果和毒性反应。疗程更短的放疗方案能够减少总体治疗时间,并缩短手术干预或全身治疗的延迟。此外,它还可能提高患者依从性并降低医疗成本。本综述综合了当前关于大分割放疗在软组织肉瘤治疗中应用的证据,并概述了大分割放疗在软组织肉瘤治疗中的潜在应用方式。